Overview

A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2026-02-27

Target enrollment:

Participant gender:

Summary

This study is to generate post-marketing safety and effectiveness data of inclisiran sodium in Indian patients as per approved indication i.e., primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia that more closely resembles the real-world population intended to be treated with inclisiran sodium.

Phase:

PHASE4

Details

Lead Sponsor:

Novartis Pharmaceuticals

Treatments:

ALN-PCS